Plasmid DNA Contract Manufacturing Market 2030: The Impact of COVID-19 on Growth
Plasmid DNA Contract Manufacturing Market Growth & Trends The global plasmid DNA contract manufacturing market size is expected to reach USD 1,117.5 million by 2030, registering a CAGR of 19.3%, according to a new report by Grand View Research, Inc. The growing popularity of cell & gene therapy, prevalence of chronic diseases is increasing and plasmid DNA has a wide range of uses in the healthcare sector are the key factors driving the growth of the market. The field of gene therapy significantly broaden the treatment of viral infections, malignancies, hereditary illnesses, and immunotherapy. The therapy is, however, not yet widely used in clinical settings, and licenses have often only been given in particular countries. Examples of gene treatments include Spinraza, which is used to treat spinal muscular atrophy. However, government assistance, assuring sustainability, community involvement, enacting suitable regulatory legislation, and promoting entrepren...